TITLE

Croatian International Publications

PUB. DATE
October 2006
SOURCE
Croatian Medical Journal;2006, Vol. 47 Issue 5, p796
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts of medical research. They include "The herpesviral Fc receptor fcr-1 downregulates the NKG2D ligands MULT-1 and H60," "Increased pulmonary vascular resistance and reduced stroke volume in association with CO2 retention and inferior vena cava dilatation" and "Role of angiogenesis in chronic lymphocytic leukemia."
ACCESSION #
22801578

 

Related Articles

  • Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Kini, A R; Kay, N E; Peterson, L C // Leukemia (08876924);Aug2000, Vol. 14 Issue 8, p1414 

    Recent studies have shown that angiogenesis may be involved in the pathogenesis of hematopoietic malignancies, apart from its well-characterized role in the growth and metastasis of solid tumors. In this study, we quantified the degree of angiogenesis in B cell chronic lymphocytic leukemia...

  • Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Bauvois, B; Dumont, J; Mathiot, C; Kolb, J-P // Leukemia (08876924);May2002, Vol. 16 Issue 5, p791 

    Besides vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), matrix metalloproteinases (MMPs) play critical roles in angiogenesis, tumor invasion and metastasis. Increased angiogenesis is observed in chronic B lymphocytic leukemia (B-CLL) and published data...

  • Chronic Lymphocytic Leukemia: New Insights into Biology and Therapy. Foon, Kenneth A.; Rai, Kanti R.; Gale, Robert Peter // Annals of Internal Medicine;10/1/90, Vol. 113 Issue 7, p525 

    Deals with a study which reviewed the advances in the biologic and clinical research of chronic lymphocytic leukemia. Information on chronic lymphocytic leukemia; Epidemiology and etiology; Indications for initiating therapy.

  • Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Jantunen, E.; Itälä, M.; Siitonen, T.; Kuittinen, T.; Heiskanen, J.; Koivunen, E.; Juvonen, E.; Silvennoinen, R.; Nousiainen, T.; Koistinen, P.; Volin, L.; Remes, K. // Bone Marrow Transplantation;Feb2008, Vol. 41 Issue 3, p239 

    Some reports suggest that blood stem cell mobilization is difficult in a proportion of patients with CLL. We evaluated this issue in a large cohort of CLL patients. One hundred and twenty-eight patients with CLL underwent blood stem cell mobilization during 1995–2005 in Finland....

  • Chronic lymphocytic leukemia radiogenicity: a systematic review. Sharon Silver; Shannon Hiratzka; Mary Schubauer-Berigan; Robert Daniels // Cancer Causes & Control;Dec2007, Vol. 18 Issue 10, p1077 

    Abstract Objective  Chronic lymphocytic leukemia (CLL) is generally considered to be non-radiogenic and is excluded from several programs that compensate workers for illnesses resulting from occupational exposures. Questions about whether this exclusion is justified prompted a...

  • Chronic Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2006, Vol. 14 Issue 2, p48 

    Presents abstracts of medical research on chronic leukemia. "Fludarabine Plus Cyclophosphamide Versus Fludarabine Alone in First-Line Therapy of Younger Patients With Chronic Lymphocytic Leukemia," by R. Busch et al; "Results of Alemtuzumab-Based Reduced Intensity Allogeneic Transplantation for...

  • Chronic Lymphocytic Leukemia: Recent Advances in Diagnosis and Treatment. Brian L. Abbott // Oncologist;Jan2006, Vol. 11 Issue 1, p21 

    Chronic lymphocytic leukemia (CLL) is a low-grade B-lineage lymphoid malignancy but may have more heterogeneity than previously thought. Many cases require no treatment at all because of an indolent course, while other patients become symptomatic or develop signs of rapid progression. Treatment...

  • Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia. Giannopoulos, K.; Dmoszynska, A.; Kowal, M.; Rolinski, J.; Gostick, E.; Price, D. A.; Greiner, J.; Rojewski, M.; Stilgenbauer, S.; Döhner, H.; Schmitt, M.; Döhner, H // Leukemia (08876924);Apr2010, Vol. 24 Issue 4, p798 

    The receptor for hyaluronic acid-mediated motility (RHAMM) is a tumor-associated antigen in chronic lymphocytic leukemia (CLL). CD8(+) T cells primed with the RHAMM-derived epitope R3, which is restricted by human leukocyte antigen (HLA)-A2, effectively lyse RHAMM(+) CLL cells. Therefore, we...

  • Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage B-Cell Chronic Lymphocytic Leukemia. Wolowiec, Dariusz; Dybko, Jaroslaw; Wr�bel, Tomasz; Urbaniak-Kujda, Donata; Jazwiec, Bozena; Tomaszewska-Toporska, Beata; Kapelko-Slowik, Katarzyna; Potoczek, Stanislaw; Kuliczkowski, Kazimierz // Mediators of Inflammation;6/1/2006, Vol. 2006 Issue 3, p1 

    Syndecan-1 (CD138) is a transmembrane heparin sulfate proteoglycan expressed on distinct stages of differentiation of B-lymphoid cells. Its prognostic value in B-cell chronic lymphocytic leukemia (B-CLL) has not been evaluated so far. The serum concentration of sCD138 and some...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics